Home / Heparin / United States
US ATC B01AB01 · updated 2 Nov 2026
Heparin shortage in United States
Is there a Heparin shortage in United States?
Yes. As of 2 Nov 2026, 8 Heparin products are reported short in United States, the first since 14 Nov 2017. No return date has been given. Main reason: not stated.
Also short in Canada, Italy, Austria, Switzerland. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Heparin Sodium 1,000 Units In Sodium Chloride 0.9% In Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-10) limited | B. Braun Medical Inc. | 14 Nov 2017 | not given | Other |
| US | Heparin Sodium 2,000 Units in Sodium Chloride 0.9% in Plastic Container, Injection, 200 [USP'U]/100 mL (NDC 0264-9872-00) limited | B. Braun Medical Inc. | 14 Nov 2017 | not given | Other |
| US | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0431-03) limited | Baxter Healthcare | 14 Nov 2017 | not given | Increased demand Demand increase for the drug |
| US | Heparin Sodium In Sodium Chloride, Injection, 200 [USP'U]/100 mL (NDC 0338-0433-04) | Baxter Healthcare | 14 Nov 2017 | not given | Not stated |
| US | Heparin Sodium, Injection, 1,000 Units/500 mL (2 Units/mL) (NDC 0409-1005-20) | Hospira, Inc., a Pfizer Company | 14 Nov 2017 | not given | Not stated |
| US | Heparin Sodium, Injection, 2,000 Units/1,000 mL (2 Units/mL) (NDC 0409-2222-12) | Hospira, Inc., a Pfizer Company | 14 Nov 2017 | not given | Not stated |
| US | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-10) | Fresenius Kabi USA, LLC | 14 Nov 2017 | not given | Not stated |
| US | Heparin Sodium, Injection, 200 [USP'U]/100 mL (NDC 63323-519-77) | Fresenius Kabi USA, LLC | 14 Nov 2017 | not given | Other |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).